Patent details
301288
Product Name:
vonicog alfa
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
301288
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3858375
Status:
Application Pending
Application number:
301288
Procedural language:
Dutch
First Applicant Residence Country:
Japan (JP)
Marketing Authorization
Marketing Authorization Number:
EU/1/18/1298
Marketing Authorization Type:
EEA
Marketing Authorization Date:
04/09/2018
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
28/08/2024
First Marketing Authorization date:
04/09/2018
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
29/08/2024
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
28/08/2024
Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome, Chuo-ku
Osaka-shi, Osaka, Japan (JP)
Agent
Name:
ir. A. Blokland c.s.
From:
28/08/2024
Address:
Algemeen Octrooi- en Merkenbureau B.V.
Postbus 645, 5600 AP, Eindhoven, Netherlands (NL)
To:
Publication
Bulletin
Bulletin Heading:
SPC
Journal edition number:
36/24
Publication date:
04/09/2024
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date
Document type
Document Description
Number of pages
File Type
29/08/2024
Outgoing Correspondence
Confirmation receipt request
2
PDF
/9/9/5/5/3/0801035599/docs/301288_10_619920l174.pdf
28/08/2024
Application Form
First filed application form
4
PDF
/9/9/5/5/3/0801035599/docs/301288_0_applicationform20240829020933814.pdf
28/08/2024
SPC Documents
Annex SPC
3
PDF
/9/9/5/5/3/0801035599/docs/301288_1_supplprotectioncertificate20240829021334416.pdf
28/08/2024
SPC Documents
Annex SPC
21
PDF
/9/9/5/5/3/0801035599/docs/301288_2_supplprotectioncertificate20240829021334425.pdf
28/08/2024
SPC Documents
Accompanying letter SPC
3
PDF
/9/9/5/5/3/0801035599/docs/301288_3_supplprotectioncertificate20240829021523415.pdf
28/08/2024
SPC Documents
Annex SPC
113
PDF
/9/9/5/5/3/0801035599/docs/301288_4_supplprotectioncertificate20240829021545527.pdf
28/08/2024
SPC Documents
Annex SPC
3
PDF
/9/9/5/5/3/0801035599/docs/301288_5_supplprotectioncertificate20240829021613748.pdf
28/08/2024
SPC Documents
Annex SPC
131
PDF
/9/9/5/5/3/0801035599/docs/301288_6_supplprotectioncertificate20240829021631196.pdf
28/08/2024
SPC Documents
Marketing Authorization SPC
3
PDF
/9/9/5/5/3/0801035599/docs/301288_7_supplprotectioncertificate20240829021648413.pdf
28/08/2024
SPC Documents
Annex SPC
4
PDF
/9/9/5/5/3/0801035599/docs/301288_8_supplprotectioncertificate20240829021723815.pdf
28/08/2024
SPC Documents
Summary of the characteristics of the product
15
PDF
/9/9/5/5/3/0801035599/docs/301288_9_supplprotectioncertificate20240829021334400.pdf